Patents by Inventor Pietro Ciceri

Pietro Ciceri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10324092
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: June 18, 2019
    Assignee: Eurofins DiscoverX Corporation
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel K. Treiber, Lisa Wodicka
  • Publication number: 20150377886
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Application
    Filed: July 28, 2015
    Publication date: December 31, 2015
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel K. Treiber, Lisa Wodicka
  • Patent number: 9110054
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: August 18, 2015
    Assignee: DiscoveRx Corporation
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel Treiber, Lisa Wodicka
  • Patent number: 7897381
    Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: March 1, 2011
    Assignee: Ambit Biosciences Corporation
    Inventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
  • Patent number: 7833741
    Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: November 16, 2010
    Assignee: Ambit Biosciences Corporation
    Inventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
  • Publication number: 20090053701
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Application
    Filed: June 29, 2007
    Publication date: February 26, 2009
    Applicant: Ambit Biosciences Corp.
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel Treiber, Lisa Wodicka
  • Publication number: 20080318298
    Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.
    Type: Application
    Filed: October 31, 2007
    Publication date: December 25, 2008
    Applicant: Ambit Biosciences Corp.
    Inventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
  • Patent number: 7323490
    Abstract: The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.
    Type: Grant
    Filed: May 17, 2004
    Date of Patent: January 29, 2008
    Assignee: Ambit Biosciences Corporation
    Inventors: David J. Lockhart, Hitesh K. Patel, Zdravko V. Milanov, Shamal Anil Mehta, Patrick Parvis Zarrinkar, William H. Biggs, III, Pietro Ciceri, Miles A. Fabian, Daniel K. Treiber
  • Publication number: 20070105093
    Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.
    Type: Application
    Filed: September 22, 2006
    Publication date: May 10, 2007
    Applicant: Ambit Biosciences Corporation
    Inventors: Pietro Ciceri, Patrick Zarrinkar, Daniel Treiber, David Lockhart
  • Patent number: 7112435
    Abstract: The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: September 26, 2006
    Assignee: Ambit Biosciences Corporation
    Inventors: Pietro Ciceri, Patrick Parvis Zarrinkar, Daniel Kelly Treiber, David J. Lockhart
  • Publication number: 20050182125
    Abstract: The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, neuroinflammatory disorders, vascular disorders with an inflammatory component, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.
    Type: Application
    Filed: November 15, 2004
    Publication date: August 18, 2005
    Applicant: Ambit Biosciences Corporation
    Inventors: David Lockhart, Hitesh Patel, Zdravko Milanov, Shamal Mehta, Patrick Zarrinkar, William Biggs, Pietro Ciceri, Miles Fabian, Daniel Treiber
  • Publication number: 20040259880
    Abstract: The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.
    Type: Application
    Filed: May 18, 2004
    Publication date: December 23, 2004
    Applicant: Ambit Biosciences Corporation
    Inventors: David J. Lockhart, Hitesh K. Patel, Zdravko V. Milanov, Shamal Anil Mehta, Patrick Parvis Zarrinkar, William H. Biggs, Pietro Ciceri, Miles A. Fabian, Daniel K. Treiber